Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Break the Cycle: Adapting Break the Cycle to Reduce Initiation Into Injecting Drug Use in Tallinn, Estonia and New York City, USA

NCT03502525 is registered in ClinicalTrials.gov with New York University as lead sponsor.

NCT NCT03502525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03502525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Break the Cycle: Adapting Break the Cycle to Reduce Initiation Into Injecting Drug Use in Tallinn, Estonia and New York City, USA
Lead sponsor
New York University
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2016
Completion date
September 2, 2022
Enrollment
402 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prevention and control, substance abuse, intravenous